Ryan Spencer
CIK 1777938 · CEO and Director · last filed 2026-02-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
25
Lifetime Open-Market Net
-$1.13M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | CEO and Director | 136,000 | $15.50 | $2.11M | -$1.13M | 21 | 2026-02-10 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Director | — | $221.38 | — | $0 | 4 | 2026-01-07 |
Recent Filings · Page 2 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-13 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +9,149 | -$149.8K | EDGAR |
| 2024-02-06 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +12,621 | -$219.1K | EDGAR |
| 2023-03-01 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +30,492 | -$310.6K | EDGAR |
| 2023-02-21 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +3,454 | $34.5K | EDGAR |
| 2022-12-13 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-10 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +14,742 | -$252.4K | EDGAR |
| 2022-03-04 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | −31,068 | -$862.9K | EDGAR |
| 2022-02-14 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +91,219 | $6.7K | EDGAR |
| 2021-02-23 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Mixed | +11,561 | -$98.4K | EDGAR |
| 2021-02-05 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | +1,518 | $5.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.